Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Reumatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
A Phase IIa Multicenter, Randomized, Double-Blind, Placebo -Controlled, Parallel Group Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00425321
Desconocido
ClinicalTrials.gov
The Role of the Proprioceptive Training in Functional Recovery of Patient With Thumb Base Osteoarthritis. A Multicenter Experimental Study
OBSERVATIONAL
Inicio: 30 de may de 2021
ID: NCT04892589
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
INTERVENTIONAL
Inicio: 25 de ene de 2017
ID: NCT02760433
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 27 de dic de 2023
ID: NCT06161116
Completado
Fase 3
ClinicalTrials.gov
Medically Ill Patient Assessment of Rivaroxaban Versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk
INTERVENTIONAL
Inicio: 7 de ene de 2014
ID: NCT02111564
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to at Least One Anti-TNF-α Therapy
INTERVENTIONAL
Inicio: 15 de may de 2007
ID: NCT00476996
Completado
Fase 4
ClinicalTrials.gov
A Clinical Outcomes Study to Evaluate the Effects of IL-6 Receptor Blockade With Tocilizumab (TCZ) in Comparison With Etanercept (ETA) on the Rate of Cardiovascular Events in Patients With Moderate to Severe Rheumatoid Arthritis (RA)
INTERVENTIONAL
Inicio: 2 de ago de 2011
ID: NCT01331837
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 24 de mar de 2016
ID: NCT02708095
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3 Multicenter, Open-label Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of Subcutaneously Administered Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)
INTERVENTIONAL
Inicio: 30 de ago de 2022
ID: NCT05083182
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Guselkumab in Subjects With Active Lupus Nephritis
INTERVENTIONAL
Inicio: 15 de sept de 2020
ID: NCT04376827
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 31 de ago de 2022
ID: NCT05516758
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Participants With Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01196091
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
INTERVENTIONAL
Inicio: 17 de dic de 2018
ID: NCT03773978
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a Multicenter, Randomized, Double Blind, Parallel, Proof of Concept Study Evaluating the Efficacy and Safety of Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis Despite Prior Treatment With Advanced Therapies (bDMARD or tsDMARD)
INTERVENTIONAL
Inicio: 15 de ago de 2023
ID: NCT06028438
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy And Safety of Belimumab Administered Subcutaneously in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (SSC-ILD)
INTERVENTIONAL
Inicio: 13 de sept de 2023
ID: NCT05878717
Completado
Fase 2
ClinicalTrials.gov
A Phase 2 Study of Multiple Intravenous Doses of LY2127399 in Patients With Rheumatoid Arthritis on Concomitant Methotrexate and an Inadequate Response to TNFα Inhibitor Therapy
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00689728
Completado
Fase 2
ClinicalTrials.gov
A Long-Term, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Radiographic Study To Investigate The Safety And Efficacy Of Orally Administered SD-6010 In Subjects With Symptomatic Osteoarthritis Of The Knee
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00565812
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
INTERVENTIONAL
Inicio: 16 de ene de 2015
ID: NCT02187471
Completado
Fase 2
ClinicalTrials.gov
A Randomised, Double-Blind (With Open Comparator Etanercept Limb), Placebo-Controlled, Phase IIb, Multicentre Study to Evaluate the Efficacy of 4 Doses of AZD9056 Administered for 6 Months on the Signs and Symptoms of Rheumatoid Arthritis in Patients With Active Disease Receiving Background Methotrexate or Sulphasalazine
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00520572
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations
INTERVENTIONAL
Inicio: 19 de feb de 2025
ID: NCT06980805
Anterior
1
...
10
11
12
...
434
Siguiente
Filtros